ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

ORI Must Release Documents In Fisher Case, Judge Rules

September 8, 1995

CCOPs, Research Base Awards Are Listed

November 19, 1993

Alan Rabson Named NCI Deputy Director

August 11, 1995

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Rauscher For Cancer Program

May 20, 1977

Cooperative Group Problems, Solutions Analyzed By CTEP Staff

May 2, 1986